Alterity Therapeutics (ATHE) Return on Equity (2016 - 2021)

Alterity Therapeutics' Return on Equity history runs 6 years deep, the most recent figure standing at 0.0% for Q2 2021.

• In Q2 2021, Return on Equity changed N/A year-over-year to 0.0%; the TTM figure through Jun 2021 stood at 0.0% (changed N/A YoY), while the FY2023 annual figure was 0.0%, changed 0.0% from the prior year.
• Return on Equity was 0.0% for Q2 2021 at Alterity Therapeutics, up from 0.0% in the prior quarter.
• In the past five years, Return on Equity ranged from a high of 0.0% in Q2 2021 to a low of 0.01% in Q2 2019.
• Historically, Return on Equity has averaged 0.0% across 5 years, with a median of 0.0% in 2017.
• The sharpest annual moves came in 2017 and 2018: Return on Equity changed 0 bps in 2017, then slipped 1 bps in 2018.
• A 5-year view of Return on Equity shows it stood at 0.0% in 2017, then plunged by 1163 bps to 0.01% in 2018, then declined by 5 bps to 0.01% in 2019, then soared by 100 bps to 0.0% in 2020, then gained by 1 bps to 0.0% in 2021.
• The last three Return on Equity figures came in at 0.0% (Q2 2021), 0.0% (Q4 2020), and 0.01% (Q2 2019), per Business Quant data.